Search results
MoonLake Immunotherapeutics' (NASDAQ:MLTX) high hedge funds ownership speaks for itself as stock...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Significantly high institutional ownership implies MoonLake Immunotherapeutics' stock...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Is In A Strong Position To Grow Its Business
Simply Wall St. via Yahoo Finance· 8 months agoThere's no doubt that money can be made by owning shares of unprofitable businesses. Indeed,...
What Makes MoonLake Immunotherapeutics (MLTX) a New Buy Stock
Zacks via Yahoo Finance· 1 year agoMoonLake Immunotherapeutics (MLTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing...
Is MoonLake Immunotherapeutics (MLTX) Stock a Solid Choice Right Now?
Zacks via Yahoo Finance· 5 months agoOne stock that might be an intriguing choice for investors right now is MoonLake Immunotherapeutics...
MoonLake Immunotherapeutics' Lead Skin Disorder Candidate Continues to Deliver on Best-Efficacy...
Benzinga via Yahoo Finance· 8 months agoMoonLake Immunotherapeutics (NASDAQ: MLTX) announced 24-week topline results from its Phase 2 MIRA...
Insider Sell: CEO Santos da Silva Jorge Sells 123,615 Shares of MoonLake Immunotherapeutics (MLTX)
GuruFocus.com via Yahoo Finance· 3 months agoSantos da Silva Jorge, CEO of MoonLake Immunotherapeutics (NASDAQ:MLTX), has sold 123,615 shares of...
CFO Matthias Bodenstedt Sells 100,000 Shares of MoonLake Immunotherapeutics
GuruFocus.com via Yahoo Finance· 6 months agoMatthias Bodenstedt, the CFO of MoonLake Immunotherapeutics (NASDAQ:MLTX), executed a sale of...
Why Shares of MoonLake Immunotherapeutics Skyrocketed Monday
Motley Fool· 11 months agoShares of MoonLake Immunotherapeutics (NASDAQ: MLTX) were up more than 67% Monday afternoon as of 2...
Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path
Benzinga via Yahoo Finance· 1 year agoCantor Fitzgerald has initiated coverage on MoonLake Immunotherapeutics AG (NASDAQ: MLTX) with an...
Why MoonLake Immunotherapeutics Stock Skyrocketed This Week
Motley Fool· 11 months agoThe big gain came after the company announced positive mid-stage trial results for the nanobody...